From lab bench to market - Critical issues in tissue engineering

被引:83
|
作者
Naughton, GK [1 ]
机构
[1] Adv Tissue Sci Inc, La Jolla, CA 92037 USA
关键词
scaffolds; bioreactors; cryopreservation;
D O I
10.1111/j.1749-6632.2002.tb03127.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Revolutionary advances in tissue engineering are redefining approaches to tissue repair and transplantation through the creation of replacement tissues that remain biointeractive after implantation, imparting physiologic functions as well as structure to the tissue or organ damaged by disease or trauma. 1,2 Over the last decade this field has moved from "science fiction" to "science fact" with the research-oriented acceptance of its potential to regulatory approvals allowing commercial products to be available for use in many countries. The maintenance of tissue integrity, functionality, and viability from cell seeding through product manufacture, shipping, and end-use has been accomplished through innovations in design and scale-up of both tissue growth and preservation processes. These unique systems have enabled the delivery of tissue-engineered products that are uniform inter- and intra-lot, readily available as off-the-shelf products, easy to use, and efficacious. Skin replacement products are the most advanced, with several tissue-engineered wound care materials on the market in the U.S. and in several international communities.(3-5) The potential impact of this field is far broader, offering novel solutions to the medical field for drug screening and development, genetic engineering, and total tissue and organ replacement.
引用
收藏
页码:372 / 385
页数:14
相关论文
共 50 条
  • [1] Tissue engineering in dermatology-from lab to market
    Nilforoushzadeh, Mohammad Ali
    Amirkhani, Mohammad Amir
    Khodaverdi, Ebrahim
    Razzaghi, Zahra
    Afzali, Hamideh
    Izadpanah, Samira
    Zare, Sona
    [J]. TISSUE & CELL, 2022, 74
  • [2] Tissue engineering a heart: Critical issues
    Sefton, MV
    Akins, R
    [J]. FUNCTIONAL TISSUE ENGINEERING, 2003, : 139 - 145
  • [3] Critical issues in vascular tissue engineering
    Nerem, R
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 265 - 265
  • [4] Keynote: Tissue engineering - from bench to bedside and back to bench
    Jungebluth, P.
    [J]. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 133 - 134
  • [5] Issues affecting nanomedicines on the way from the bench to the market
    Figueiro Longo, Joao Paulo
    Mussi, Samuel
    Azevedo, Ricardo Bentes
    Muehlmann, Luis Alexandre
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (47) : 10681 - 10685
  • [6] Bone tissue engineering: from bench to bedside
    Woodruff, Maria A.
    Lange, Claudia
    Reichert, Johannes
    Berner, Arne
    Chen, Fulen
    Fratzl, Peter
    Schantz, Jan-Thorsten
    Hutmacher, Dietmar W.
    [J]. MATERIALS TODAY, 2012, 15 (10) : 430 - 435
  • [7] Tissue Engineering of the Urethra: From Bench to Bedside
    Pastorek, Dusan
    Culenova, Martina
    Csobonyeiova, Maria
    Skuciova, Veronika
    Danisovic, Lubos
    Ziaran, Stanislav
    [J]. BIOMEDICINES, 2021, 9 (12)
  • [8] Corneal Tissue Engineering: From Bench to Clinic
    Han, Sang Beom
    Mehta, Jodhbir S.
    Liu, Yu-Chi
    Mohamed-Noriega, Karim
    [J]. JOURNAL OF OPHTHALMOLOGY, 2018, 2018
  • [9] Esophageal tissue engineering: from bench to bedside
    Arakelian, Lousineh
    Kanai, Nobuo
    Dua, Kulwinder
    Durand, Marlene
    Cattan, Pierre
    Ohki, Takeshi
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1434 (01) : 156 - 163
  • [10] Tissue engineering: From bench to bedside via commercialization
    Vacanti, Joseph P.
    [J]. SURGERY, 2008, 143 (02) : 181 - 183